Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,569 | 414 | 98.7% |
| Education | $102.85 | 2 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,554 | 184 | $0 (2024) |
| PFIZER INC. | $747.80 | 37 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $645.82 | 29 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $639.50 | 31 | $0 (2024) |
| Janssen Biotech, Inc. | $567.36 | 24 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $403.10 | 21 | $0 (2023) |
| Medtronic, Inc. | $330.93 | 2 | $0 (2022) |
| Ironwood Pharmaceuticals, Inc | $255.05 | 9 | $0 (2023) |
| Celgene Corporation | $215.07 | 11 | $0 (2024) |
| UCB, Inc. | $173.39 | 11 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,627 | 95 | ABBVIE INC. ($534.41) |
| 2023 | $1,468 | 89 | ABBVIE INC. ($366.71) |
| 2022 | $1,236 | 79 | ABBVIE INC. ($476.14) |
| 2021 | $947.86 | 40 | AbbVie Inc. ($414.49) |
| 2020 | $170.81 | 11 | AbbVie Inc. ($121.59) |
| 2019 | $505.90 | 24 | PFIZER INC. ($248.14) |
| 2018 | $941.75 | 36 | AbbVie, Inc. ($375.05) |
| 2017 | $774.35 | 42 | AbbVie, Inc. ($249.25) |
All Payment Transactions
416 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $19.41 | General |
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $34.76 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $0.31 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/06/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $10.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Immunology | ||||||
| 10/24/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $16.34 | General |
| 10/08/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/03/2024 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Genetic Disease | ||||||
| 09/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.56 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $21.41 | General |
| 09/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: IMMUNOLOGY | ||||||
| 09/05/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 08/22/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: IMMUNOLOGY | ||||||
| 08/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $29.07 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 528 | 564 | $559,135 | $61,964 |
| 2022 | 12 | 698 | 754 | $728,505 | $78,965 |
| 2021 | 15 | 744 | 816 | $662,960 | $86,124 |
| 2020 | 18 | 889 | 963 | $719,021 | $100,041 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 112 | 114 | $221,730 | $23,709 | 10.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 117 | $23,400 | $10,338 | 44.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 47 | 48 | $13,200 | $6,390 | 48.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 85 | 85 | $156,825 | $5,129 | 3.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 59 | 60 | $78,600 | $4,574 | 5.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 59 | 62 | $8,680 | $4,096 | 47.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 17 | 17 | $29,920 | $3,125 | 10.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 25 | 29 | $3,770 | $1,844 | 48.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $4,335 | $1,820 | 42.0% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $18,675 | $940.13 | 5.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 116 | 118 | $229,510 | $24,325 | 10.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 102 | 135 | $27,000 | $12,351 | 45.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 53 | 55 | $15,125 | $8,820 | 58.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 48 | 50 | $88,000 | $7,157 | 8.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 97 | 100 | $131,000 | $6,970 | 5.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 99 | 107 | $14,980 | $6,945 | 46.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 97 | 98 | $180,810 | $5,764 | 3.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 25 | 25 | $6,375 | $2,480 | 38.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 27 | 32 | $4,160 | $1,858 | 44.7% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 12 | 12 | $16,200 | $1,410 | 8.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 11 | 11 | $13,695 | $854.42 | 6.2% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 11 | 11 | $1,650 | $31.25 | 1.9% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 111 | 112 | $217,840 | $23,613 | 10.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 121 | 142 | $19,696 | $10,285 | 52.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 61 | 62 | $17,050 | $10,202 | 59.8% |
About Dr. Thomas Mcgreen, M.D
Dr. Thomas Mcgreen, M.D is a Gastroenterology healthcare provider based in Cranston, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1043205537.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Mcgreen, M.D has received a total of $7,672 in payments from pharmaceutical and medical device companies, with $1,627 received in 2024. These payments were reported across 416 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($7,569).
As a Medicare-enrolled provider, Mcgreen has provided services to 2,859 Medicare beneficiaries, totaling 3,097 services with total Medicare billing of $327,093. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Cranston, RI
- Active Since 09/12/2005
- Last Updated 10/15/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1043205537
Products in Payments
- RINVOQ (Biological) $825.94
- XELJANZ (Drug) $718.09
- ENTYVIO (Biological) $627.70
- TRULANCE (Drug) $504.40
- HUMIRA (Biological) $458.55
- STELARA (Biological) $457.34
- ZENPEP (Drug) $403.10
- LINZESS (Drug) $372.74
- SKYRIZI (Biological) $301.30
- GI Genius (Device) $278.76
- Humira (Biological) $270.22
- Creon (Drug) $246.21
- ZEPOSIA (Drug) $179.49
- Cimzia (Drug) $173.39
- CREON (Drug) $144.29
- OCALIVA (Drug) $116.12
- Trulance (Drug) $101.15
- DOPTELET (Drug) $97.44
- Alinia Tablets 500mg 30 count bottle (Drug) $97.02
- Mavyret (Drug) $81.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Cranston
Morris Elevado, M.d, M.D
Gastroenterology — Payments: $327,895
Colin Woodard, Do, DO
Gastroenterology — Payments: $8,820
Robert Wolfgang, D.o, D.O
Gastroenterology — Payments: $6,692
George Powers, M.d, M.D
Gastroenterology — Payments: $1,319
Paul Roderick, M.d, M.D
Gastroenterology — Payments: $1,317
Philip Opalenski, Md, MD
Gastroenterology — Payments: $568.20